Survey: Lived experience & Quality of life

Oct 5, 2024

Call for participants – “Exploring the lived experiences and quality of life of individuals affected by CAH”

If you’re 18 years and over and living with CAH, tell us how CAH affects your life in an individual discussion held at a convenient time face-to-face or online.

The aim of this study is to find out how CAH affects the quality of life of people affected by this condition. We will be carrying out interviews with people affected by CAH to find out how having this condition affects people’s daily lives and well-being at different stages in their life. The study findings will be used to help us develop a quality of life questionnaire that focuses on the unique issues affecting people with CAH. The questionnaire could eventually be used by health professionals and researchers to improve the care of individuals with the condition.

Individuals over the age of 18 with a diagnosis of CAH are eligible to take part in this study. Partners or relatives of people with CAH are also welcome to participate. The study will involve a one-to-one online or face-to-face interview at a convenient date and time. We expect the interviews to last about an hour. A £20 Amazon voucher will be provided to people who take part as reimbursement for their time.

The research is being led by Professor Aled Rees, Professor of Endocrinology and Consultant Endocrinologist Cardiff University, in collaboration with Cardiff Metropolitan University and Living with CAH. The study has been approved by the Cardiff University School of Medicine Research Ethics Committee: 24/32.

 If you are interested in taking part in the study, download the flier here.

Recent Blog Posts

What you should know about COVID-19 – updated 10th August 2021

What you should know about COVID-19 – updated 10th August 2021

Guidance from other organizations is continually being issued and we'll do our best to link to them below - please keep checking back here for more updates. UPDATE 10th August 2021 Article: “ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises”...

Survey: Paediatric Adrenal Insufficiency Education

Survey: Paediatric Adrenal Insufficiency Education

This project, led by Edge Hill University is working with NHS clinicians to develop national education standards and resources for sick day/emergency management of adrenal insufficiency in children and young people. The project would like to hear the views of parents...

Treatment Research Update – Crinetics Atumelnant (CRN04894)

Treatment Research Update – Crinetics Atumelnant (CRN04894)

Atumelnant (CRN04894) is in development by Crinetics for the treatment of congenital adrenal hyperplasia (CAH) and ACTH-dependent Cushing's syndrome. It is an oral, selective ACTH antagonist. Atumelnant is now in Phase 2 of development and you can read the latest...

The CAH Support Group is affiliated with Society for Endocrinology, an organisation that supports clinicians, scientists and nurses who work with hormones throughout their careers. They engage policy-makers, journalists, patients and the public with hormone science to encourage informed health decisions, and to demonstrate the value of endocrinology to the wider world and also maintains a public information website, You and Your Hormones.

All content on this website (livingwithcah.com) is copyright the CAH Support Group unless otherwise stated.

The CAH Support Group cannot be held responsible for the content provided by any external links unless stated.

Cookie Policy | Privacy Policy | Disclaimer | Forum & Social Media Rules | Contact Us